Hayes News

Hayes News Service keeps our clients up to date with late-breaking news from clinical trials, coverage decisions, and new product approvals. We focus on emerging technologies with potentially high clinical and financial impact as soon as they are announced publicly.

Our analysts scan more than 75 peer-reviewed journals and news briefings from government agencies, medical associations, and research institutes. Results of selected studies or articles are summarized and posted with a brief commentary on whether the findings are likely to have a substantial impact.

    WHO Recommends Against Use of Remdesivir in COVID-19

    The World Health Organization (WHO) has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, citing a lack of evidence that remdesivir improves survival and other outcomes in these patients.

    read more

    COVID-19 Vaccine Candidate Achieved Success in First Interim Analysis

    Pfizer Inc. and BioNTech SE have announced an interim analysis from a phase III trial of their COVID-19 vaccine candidate. Based on the first interim efficacy analysis, the mRNA-based vaccine candidate, BNT162b2, has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection.

    read more

    FDA Safety Alert: Medtronic Rashkind Balloon Septostomy Catheters

    Medtronic Inc. is recalling Rashkind Balloon Septostomy Catheters because of device quality issues that may lead to the device breaking, separating, or failing during use. If this occurs, use of the affected product may cause serious adverse health consequences, such as vascular injury and death.

    read more

    USPSTF Draft Guidance: Colorectal Cancer Screening

    The United States Preventive Services Task Force (USPSTF) has released a new draft recommendation statement on screening for colorectal cancer. The draft statement includes a new recommendation for screening for colorectal cancer in adults ages 45 to 49 years.

    read more

    USPSTF Draft Guidance: Colorectal Cancer Screening

    The United States Preventive Services Task Force (USPSTF) has released a new draft recommendation statement on screening for colorectal cancer. The draft statement includes a new recommendation for screening for colorectal cancer in adults ages 45 to 49 years.

    read more